Morning Market Losers
September 09, 2013 at 10:09 AM EDT
Biodel (NASDAQ: BIOD ) dropped 16.10% to $4.22 after the company's BIOD-123 achieved primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog. GW Pharmaceuticals plc (NASDAQ: GWPH ) plummeted 13.60% to $14.17. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%. Orbital Corporation Limited (NYSE: OBT )
